Cargando…
Biological and Molecular Docking Evaluation of a Benzylisothiocyanate Semisynthetic Derivative From Moringa oleifera in a Pre-clinical Study of Temporomandibular Joint Pain
OBJECTIVE: Moringa oleifera possesses multiple biological effects and the 4-[(4′-O-acetyl-α-L- rhamnosyloxy) benzyl] isothiocyanate accounts for them. Based on the original isothiocyanate molecule we obtained a semisynthetic derivative, named 4-[(2′,3′,4′-O-triacetyl-α-L-rhamnosyloxy) N-benzyl] hydr...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9083263/ https://www.ncbi.nlm.nih.gov/pubmed/35546897 http://dx.doi.org/10.3389/fnins.2022.742239 |
_version_ | 1784703384771624960 |
---|---|
author | Silveira, Felipe Dantas Gomes, Francisco Isaac Fernandes do Val, Danielle Rocha Freitas, Hermany Capistrano de Assis, Ellen Lima de Almeida, Diana Kelly Castro Braz, Helyson Lucas Bezerra Barbosa, Francisco Geraldo Mafezoli, Jair da Silva, Marcos Reinaldo Jorge, Roberta Jeane Bezerra Clemente-Napimoga, Juliana Trindade Costa, Deiziane Viana da Silva Brito, Gerly Anne de Castro Pinto, Vicente de Paulo Teixeira Cristino-Filho, Gerardo Bezerra, Mirna Marques Chaves, Hellíada Vasconcelos |
author_facet | Silveira, Felipe Dantas Gomes, Francisco Isaac Fernandes do Val, Danielle Rocha Freitas, Hermany Capistrano de Assis, Ellen Lima de Almeida, Diana Kelly Castro Braz, Helyson Lucas Bezerra Barbosa, Francisco Geraldo Mafezoli, Jair da Silva, Marcos Reinaldo Jorge, Roberta Jeane Bezerra Clemente-Napimoga, Juliana Trindade Costa, Deiziane Viana da Silva Brito, Gerly Anne de Castro Pinto, Vicente de Paulo Teixeira Cristino-Filho, Gerardo Bezerra, Mirna Marques Chaves, Hellíada Vasconcelos |
author_sort | Silveira, Felipe Dantas |
collection | PubMed |
description | OBJECTIVE: Moringa oleifera possesses multiple biological effects and the 4-[(4′-O-acetyl-α-L- rhamnosyloxy) benzyl] isothiocyanate accounts for them. Based on the original isothiocyanate molecule we obtained a semisynthetic derivative, named 4-[(2′,3′,4′-O-triacetyl-α-L-rhamnosyloxy) N-benzyl] hydrazine carbothioamide (MC-H) which was safe and effective in a temporomandibular joint (TMJ) inflammatory hypernociception in rats. Therefore, considering that there is still a gap in the knowledge concerning the mechanisms of action through which the MC-H effects are mediated, this study aimed to investigate the involvement of the adhesion molecules (ICAM-1, CD55), the pathways heme oxygenase-1 (HO-1) and NO/cGMP/PKG/K(+)(ATP), and the central opioid receptors in the efficacy of the MC-H in a pre-clinical study of TMJ pain. METHODS: Molecular docking studies were performed to test the binding performance of MC-H against the ten targets of interest (ICAM-1, CD55, HO-1, iNOS, soluble cGMP, cGMP-dependent protein kinase (PKG), K(+)(ATP) channel, mu (μ), kappa (κ), and delta (δ) opioid receptors). In in vivo studies, male Wistar rats were treated with MC-H 1 μg/kg before TMJ formalin injection and nociception was evaluated. Periarticular tissues were removed to assess ICAM-1 and CD55 protein levels by Western blotting. To investigate the role of HO-1 and NO/cGMP/PKG/K(+)(ATP) pathways, the inhibitors ZnPP-IX, aminoguanidine, ODQ, KT5823, or glibenclamide were used. To study the involvement of opioid receptors, rats were pre-treated (15 min) with an intrathecal injection of non-selective inhibitor naloxone or with CTOP, naltrindole, or norbinaltorphimine. RESULTS: All interactions presented acceptable binding energy values (below −6.0 kcal/mol) which suggest MC-H might strongly bind to its molecular targets. MC-H reduced the protein levels of ICAM-1 and CD55 in periarticular tissues. ZnPP-IX, naloxone, CTOP, and naltrindole reversed the antinociceptive effect of MC-H. CONCLUSION: MC-H demonstrated antinociceptive and anti-inflammatory effects peripherally by the activation of the HO-1 pathway, as well as through inhibition of the protein levels of adhesion molecules, and centrally by μ and δ opioid receptors. |
format | Online Article Text |
id | pubmed-9083263 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-90832632022-05-10 Biological and Molecular Docking Evaluation of a Benzylisothiocyanate Semisynthetic Derivative From Moringa oleifera in a Pre-clinical Study of Temporomandibular Joint Pain Silveira, Felipe Dantas Gomes, Francisco Isaac Fernandes do Val, Danielle Rocha Freitas, Hermany Capistrano de Assis, Ellen Lima de Almeida, Diana Kelly Castro Braz, Helyson Lucas Bezerra Barbosa, Francisco Geraldo Mafezoli, Jair da Silva, Marcos Reinaldo Jorge, Roberta Jeane Bezerra Clemente-Napimoga, Juliana Trindade Costa, Deiziane Viana da Silva Brito, Gerly Anne de Castro Pinto, Vicente de Paulo Teixeira Cristino-Filho, Gerardo Bezerra, Mirna Marques Chaves, Hellíada Vasconcelos Front Neurosci Neuroscience OBJECTIVE: Moringa oleifera possesses multiple biological effects and the 4-[(4′-O-acetyl-α-L- rhamnosyloxy) benzyl] isothiocyanate accounts for them. Based on the original isothiocyanate molecule we obtained a semisynthetic derivative, named 4-[(2′,3′,4′-O-triacetyl-α-L-rhamnosyloxy) N-benzyl] hydrazine carbothioamide (MC-H) which was safe and effective in a temporomandibular joint (TMJ) inflammatory hypernociception in rats. Therefore, considering that there is still a gap in the knowledge concerning the mechanisms of action through which the MC-H effects are mediated, this study aimed to investigate the involvement of the adhesion molecules (ICAM-1, CD55), the pathways heme oxygenase-1 (HO-1) and NO/cGMP/PKG/K(+)(ATP), and the central opioid receptors in the efficacy of the MC-H in a pre-clinical study of TMJ pain. METHODS: Molecular docking studies were performed to test the binding performance of MC-H against the ten targets of interest (ICAM-1, CD55, HO-1, iNOS, soluble cGMP, cGMP-dependent protein kinase (PKG), K(+)(ATP) channel, mu (μ), kappa (κ), and delta (δ) opioid receptors). In in vivo studies, male Wistar rats were treated with MC-H 1 μg/kg before TMJ formalin injection and nociception was evaluated. Periarticular tissues were removed to assess ICAM-1 and CD55 protein levels by Western blotting. To investigate the role of HO-1 and NO/cGMP/PKG/K(+)(ATP) pathways, the inhibitors ZnPP-IX, aminoguanidine, ODQ, KT5823, or glibenclamide were used. To study the involvement of opioid receptors, rats were pre-treated (15 min) with an intrathecal injection of non-selective inhibitor naloxone or with CTOP, naltrindole, or norbinaltorphimine. RESULTS: All interactions presented acceptable binding energy values (below −6.0 kcal/mol) which suggest MC-H might strongly bind to its molecular targets. MC-H reduced the protein levels of ICAM-1 and CD55 in periarticular tissues. ZnPP-IX, naloxone, CTOP, and naltrindole reversed the antinociceptive effect of MC-H. CONCLUSION: MC-H demonstrated antinociceptive and anti-inflammatory effects peripherally by the activation of the HO-1 pathway, as well as through inhibition of the protein levels of adhesion molecules, and centrally by μ and δ opioid receptors. Frontiers Media S.A. 2022-04-25 /pmc/articles/PMC9083263/ /pubmed/35546897 http://dx.doi.org/10.3389/fnins.2022.742239 Text en Copyright © 2022 Silveira, Gomes, do Val, Freitas, de Assis, de Almeida, Braz, Barbosa, Mafezoli, da Silva, Jorge, Clemente-Napimoga, Costa, Brito, Pinto, Cristino-Filho, Bezerra and Chaves. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neuroscience Silveira, Felipe Dantas Gomes, Francisco Isaac Fernandes do Val, Danielle Rocha Freitas, Hermany Capistrano de Assis, Ellen Lima de Almeida, Diana Kelly Castro Braz, Helyson Lucas Bezerra Barbosa, Francisco Geraldo Mafezoli, Jair da Silva, Marcos Reinaldo Jorge, Roberta Jeane Bezerra Clemente-Napimoga, Juliana Trindade Costa, Deiziane Viana da Silva Brito, Gerly Anne de Castro Pinto, Vicente de Paulo Teixeira Cristino-Filho, Gerardo Bezerra, Mirna Marques Chaves, Hellíada Vasconcelos Biological and Molecular Docking Evaluation of a Benzylisothiocyanate Semisynthetic Derivative From Moringa oleifera in a Pre-clinical Study of Temporomandibular Joint Pain |
title | Biological and Molecular Docking Evaluation of a Benzylisothiocyanate Semisynthetic Derivative From Moringa oleifera in a Pre-clinical Study of Temporomandibular Joint Pain |
title_full | Biological and Molecular Docking Evaluation of a Benzylisothiocyanate Semisynthetic Derivative From Moringa oleifera in a Pre-clinical Study of Temporomandibular Joint Pain |
title_fullStr | Biological and Molecular Docking Evaluation of a Benzylisothiocyanate Semisynthetic Derivative From Moringa oleifera in a Pre-clinical Study of Temporomandibular Joint Pain |
title_full_unstemmed | Biological and Molecular Docking Evaluation of a Benzylisothiocyanate Semisynthetic Derivative From Moringa oleifera in a Pre-clinical Study of Temporomandibular Joint Pain |
title_short | Biological and Molecular Docking Evaluation of a Benzylisothiocyanate Semisynthetic Derivative From Moringa oleifera in a Pre-clinical Study of Temporomandibular Joint Pain |
title_sort | biological and molecular docking evaluation of a benzylisothiocyanate semisynthetic derivative from moringa oleifera in a pre-clinical study of temporomandibular joint pain |
topic | Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9083263/ https://www.ncbi.nlm.nih.gov/pubmed/35546897 http://dx.doi.org/10.3389/fnins.2022.742239 |
work_keys_str_mv | AT silveirafelipedantas biologicalandmoleculardockingevaluationofabenzylisothiocyanatesemisyntheticderivativefrommoringaoleiferainapreclinicalstudyoftemporomandibularjointpain AT gomesfranciscoisaacfernandes biologicalandmoleculardockingevaluationofabenzylisothiocyanatesemisyntheticderivativefrommoringaoleiferainapreclinicalstudyoftemporomandibularjointpain AT dovaldaniellerocha biologicalandmoleculardockingevaluationofabenzylisothiocyanatesemisyntheticderivativefrommoringaoleiferainapreclinicalstudyoftemporomandibularjointpain AT freitashermanycapistrano biologicalandmoleculardockingevaluationofabenzylisothiocyanatesemisyntheticderivativefrommoringaoleiferainapreclinicalstudyoftemporomandibularjointpain AT deassisellenlima biologicalandmoleculardockingevaluationofabenzylisothiocyanatesemisyntheticderivativefrommoringaoleiferainapreclinicalstudyoftemporomandibularjointpain AT dealmeidadianakellycastro biologicalandmoleculardockingevaluationofabenzylisothiocyanatesemisyntheticderivativefrommoringaoleiferainapreclinicalstudyoftemporomandibularjointpain AT brazhelysonlucasbezerra biologicalandmoleculardockingevaluationofabenzylisothiocyanatesemisyntheticderivativefrommoringaoleiferainapreclinicalstudyoftemporomandibularjointpain AT barbosafranciscogeraldo biologicalandmoleculardockingevaluationofabenzylisothiocyanatesemisyntheticderivativefrommoringaoleiferainapreclinicalstudyoftemporomandibularjointpain AT mafezolijair biologicalandmoleculardockingevaluationofabenzylisothiocyanatesemisyntheticderivativefrommoringaoleiferainapreclinicalstudyoftemporomandibularjointpain AT dasilvamarcosreinaldo biologicalandmoleculardockingevaluationofabenzylisothiocyanatesemisyntheticderivativefrommoringaoleiferainapreclinicalstudyoftemporomandibularjointpain AT jorgerobertajeanebezerra biologicalandmoleculardockingevaluationofabenzylisothiocyanatesemisyntheticderivativefrommoringaoleiferainapreclinicalstudyoftemporomandibularjointpain AT clementenapimogajulianatrindade biologicalandmoleculardockingevaluationofabenzylisothiocyanatesemisyntheticderivativefrommoringaoleiferainapreclinicalstudyoftemporomandibularjointpain AT costadeizianevianadasilva biologicalandmoleculardockingevaluationofabenzylisothiocyanatesemisyntheticderivativefrommoringaoleiferainapreclinicalstudyoftemporomandibularjointpain AT britogerlyannedecastro biologicalandmoleculardockingevaluationofabenzylisothiocyanatesemisyntheticderivativefrommoringaoleiferainapreclinicalstudyoftemporomandibularjointpain AT pintovicentedepauloteixeira biologicalandmoleculardockingevaluationofabenzylisothiocyanatesemisyntheticderivativefrommoringaoleiferainapreclinicalstudyoftemporomandibularjointpain AT cristinofilhogerardo biologicalandmoleculardockingevaluationofabenzylisothiocyanatesemisyntheticderivativefrommoringaoleiferainapreclinicalstudyoftemporomandibularjointpain AT bezerramirnamarques biologicalandmoleculardockingevaluationofabenzylisothiocyanatesemisyntheticderivativefrommoringaoleiferainapreclinicalstudyoftemporomandibularjointpain AT chaveshelliadavasconcelos biologicalandmoleculardockingevaluationofabenzylisothiocyanatesemisyntheticderivativefrommoringaoleiferainapreclinicalstudyoftemporomandibularjointpain |